Ran Nussbaum Insider Trading $URGN UroGen Pharma Ltd.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ran Nussbaum.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ran Nussbaum. Ran Nussbaum is Director in ARQULE INC ($ARQL) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Kite Pharma, Inc. ($KITE) and Director in Keros Therapeutics, Inc. ($KROS) and Director in UroGen Pharma Ltd. ($URGN) and Director in Prevail Therapeutics Inc. ($PRVL).

Ran Nussbaum in UroGen Pharma Ltd.

Trading Symbol: URGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ran Nussbaum: Director
Holdings: 1,465,199 shares
Latest Transaction: Apr 22 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Ran Nussbaum in UroGen Pharma Ltd.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARQL, ELOX, KROS, KITE, PRVL, URGN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 22 2021URGNUroGen Pharma Ltd.Nussbaum RanDirectorOption ExerciseM5.001,0305,1500
Apr 22 2021URGNUroGen Pharma Ltd.Nussbaum RanDirectorBuyM5.001,0305,1501,465,1991.5 M to 1.5 M (+0.07 %)
Jun 10 2020URGNUroGen Pharma Ltd.Nussbaum RanDirectorOption ExerciseA28.2410,000282,40010,000
Jun 05 2019URGNUroGen Pharma Ltd.Nussbaum RanDirectorOption ExerciseA34.8310,000348,30010,000

Page:   1